Embodiments disclosed herein are directed to negative pressure treatment systems and wound dressing systems, apparatuses, and methods that may be used for the treatment of wounds. In particular, some embodiments are directed to improved wound dressings comprising an obscuring layer that may hide fluid contained therein. Some embodiments may further comprise one or more viewing windows disposed therethrough so as to enable monitoring or examination of fluids contained therein.

The wound dressing described herein can be used as a contact layer dressing. The wound dressing can be positioned between a wound bed and a secondary dressing. The wound dressing can include a layered construction. Each of the layers can include a bioresorbable sponge enclosed within a collagen-based film. The wound dressing can include a plurality of fluid channels that enable fluid flow from the wound bed toward the environment-face side of the wound dressing.

A bandaging system relating to assisting improved wound compression, wound stability, and wound-management of wound sites and other wound care.

A dressing for wound healing is provided herein including dehydrated placental tissue, collagen, and oxidized regenerated cellulose. The dehydrated placental tissue may be present in a first layer and the collagen and the oxidized regenerated cellulose may be combined into a second layer. The dehydrated placental tissue may comprise amniotic membrane tissue, chorion tissue, or a combination thereof. The second layer including the collagen and the oxidized regenerated cellulose may comprise about 50% to about 60% collagen by weight and about 40% to about 50% ORC by weight.

As an example, in some embodiments is a dressing that may comprise a manifold, a bioresorbable component, and a degradation-modulating component. The degradation-modulating component may cover two or more surfaces of the bioresorbable component. The degradation-modulating component may be further configured to modulate degradation of the bioresorbable component.

The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.

A nasal drip pad apparatus for use on an individual. The apparatus includes a drip pad assembly positioned configured to be positioned underneath an individual's nose and a string forming configured to form a pair of loops. One of the loops is placed around one of the patient's ears and the other one of the loops is placed around the other one of the patient's ears.

A dressing configured to be positioned adjacent to a tissue site is disclosed herein. The dressing may include oxidized regenerated cellulose (ORC), collagen, and at least one nutrient including glutamine. Methods of treating a tissue site are also disclosed herein.

A chemically modified cellulosic fibre or filament having a moisture content of at least 7% by weight obtained by a process comprising the steps of (i) obtaining cellulosic fibres or filament and chemically modifying the cellulose by substitution to increase its absorbency; (ii) washing the fibres after step (i) in a mixture comprising water and up to 99% by weight of water-miscible organic solvent; (iii) drying the fibres to a moisture content of at least 7% by weight.

The stretchable porous film of the present invention includes voids in a surface thereof, in which: the stretchable porous film has an air permeability measured with an Oken-type air permeability meter of less than 99,999 sec/100 cc; the stretchable porous film has such an extending direction that an air permeability measured with the Oken-type air permeability meter in a state in which the stretchable porous film is extended by 100% becomes less than 60,000 sec/100 cc; and the stretchable porous film has such a pulling direction that when, in a hysteresis test, the stretchable porous film is pulled from a width of 20 mm and an inter-chuck distance of 30 mm to an inter-chuck distance of 60 mm at a pulling speed of 50 mm/min and held for 1 minute, and then the pulling of the inter-chuck distance is released, a residual strain becomes 10 mm or less.